WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines

Multidrug resistance (MDR) is a major reason for the failure of acute myeloid leukemia (AML) therapy. Agents that reverse MDR and sensitize AML cells to chemotherapy are of great clinical significance. The present study developed Adriamycin (Adr)-resistant cell lines, namely K562/Adr200 and K562/Adr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Rep
Autori principali: Ibrahim, Sara M., Bakhashab, Sherin, Ilyas, Asad M., Pushparaj, Peter N., Karim, Sajjad, Khan, Jalaluddin A., Abuzenadah, Adel M., Chaudhary, Adeel G., Al-Qahtani, Muhammed H., Ahmed, Farid
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2019
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489006/
https://ncbi.nlm.nih.gov/pubmed/30942458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7093
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi